ERAXIS - 0049-0114-28 - (ANIDULAFUNGIN)

Alphabetical Index


Drug Information of ERAXIS

Product NDC: 0049-0114
Proprietary Name: ERAXIS
Non Proprietary Name: ANIDULAFUNGIN
Active Ingredient(s): 50    mg/15mL & nbsp;   ANIDULAFUNGIN
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ERAXIS

Product NDC: 0049-0114
Labeler Name: Roerig
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021632
Marketing Category: NDA
Start Marketing Date: 20060217

Package Information of ERAXIS

Package NDC: 0049-0114-28
Package Description: 15 mL in 1 VIAL, SINGLE-USE (0049-0114-28)

NDC Information of ERAXIS

NDC Code 0049-0114-28
Proprietary Name ERAXIS
Package Description 15 mL in 1 VIAL, SINGLE-USE (0049-0114-28)
Product NDC 0049-0114
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ANIDULAFUNGIN
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20060217
Marketing Category Name NDA
Labeler Name Roerig
Substance Name ANIDULAFUNGIN
Strength Number 50
Strength Unit mg/15mL
Pharmaceutical Classes Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]

Complete Information of ERAXIS


General Information